Literature DB >> 19609625

Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications.

Anastasia Petsa1, Sofia Gargani, Antigonos Felesakis, Nikolaos Grigoriadis, Ioannis Grigoriadis.   

Abstract

The Wharton's Jelly (WJ) of the umbilical cord (UC) is an excellent source of mesenchymal stem cells (MSCs) with a range of potential therapeutic applications. The present study was conducted to demonstrate the efficiency of the protocols used by Biogenea-Cellgenea Ltd. for isolation and expansion of WJ MSCs from donors across Greece. Umbilical cord samples were collected from 599 females following childbirth and processed for WJ MSC isolation. Stem cells were expanded using DMEM-based media and cell counts and overall viability figures derived using Trypan blue exclusion. To investigate the application of isolation and expansion protocols on samples received 1, 2, 3, 4 and 5 d after their collection, ten fresh samples were processed at these time intervals and evaluated. The cellular yield of most WJ samples was 1.1–5.0×10(6) cells at 21–30 d after processing. As culture time increased, cell counts decreased. Statistical analysis of mean cell counts showed a significant reduction after 21 d. Finally, we demonstrate for the first time that it is possible to obtain satisfactory cell numbers from samples processed 1, 2, 3, 4 and even 5 d after collection. We have derived favourable data on the protocols used at Biogenea-Cellgenea Ltd. to isolate and culture MSCs from the WJ. Protocol choice is crucial when handling large numbers of samples on a daily basis and should be made to ensure the best possible outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609625     DOI: 10.1007/s11626-009-9227-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  13 in total

1.  Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy.

Authors:  A Banfi; A Muraglia; B Dozin; M Mastrogiacomo; R Cancedda; R Quarto
Journal:  Exp Hematol       Date:  2000-06       Impact factor: 3.084

2.  Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord.

Authors:  Yuri A Romanov; Veronika A Svintsitskaya; Vladimir N Smirnov
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

3.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 4.  Integral therapeutic potential of bone marrow mesenchymal stem cells.

Authors:  I Kan; E Melamed; D Offen
Journal:  Curr Drug Targets       Date:  2005-02       Impact factor: 3.465

5.  Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton's jelly portion of human umbilical cord.

Authors:  K D McElreavey; A I Irvine; K T Ennis; W H McLean
Journal:  Biochem Soc Trans       Date:  1991-02       Impact factor: 5.407

6.  Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation.

Authors:  Winston Costa Pereira; Italia Khushnooma; Manisha Madkaikar; K Ghosh
Journal:  J Tissue Eng Regen Med       Date:  2008-10       Impact factor: 3.963

7.  Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.

Authors:  Tiki Bakhshi; Ryan C Zabriskie; Shamanique Bodie; Shannon Kidd; Susan Ramin; Laura A Paganessi; Stephanie A Gregory; Henry C Fung; Kent W Christopherson
Journal:  Transfusion       Date:  2008-09-16       Impact factor: 3.157

8.  Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord.

Authors:  Kiran Seshareddy; Deryl Troyer; Mark L Weiss
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

9.  Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.

Authors:  Lian Ma; Xue-yong Feng; Bing-lin Cui; Frieda Law; Xue-wu Jiang; Li-Ye Yang; Qing-dong Xie; Tian-hua Huang
Journal:  Chin Med J (Engl)       Date:  2005-12-05       Impact factor: 2.628

10.  Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.

Authors:  Melissa A Baxter; Robert F Wynn; Simon N Jowitt; J Ed Wraith; Leslie J Fairbairn; Ilaria Bellantuono
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

View more
  16 in total

1.  Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells.

Authors:  Reine El Omar; Yu Xiong; Gabriel Dostert; Huguette Louis; Monique Gentils; Patrick Menu; Jean-François Stoltz; Émilie Velot; Véronique Decot
Journal:  Immunol Cell Biol       Date:  2015-10-29       Impact factor: 5.126

2.  Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Abdul Manaf Ali; Abdul Rahman Omar; Maryam Mohit; Ehsan Janzamin; Fazel Sahraneshin Samani; Zahra Torshizi; Seyed Noureddin Nematollahi-Mahani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-01-25       Impact factor: 2.416

Review 3.  Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues.

Authors:  Fatemeh Hendijani
Journal:  Cell Prolif       Date:  2017-02-01       Impact factor: 6.831

Review 4.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

5.  Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration.

Authors:  Maria Rosa Todeschi; Rania El Backly; Chiara Capelli; Antonio Daga; Eugenio Patrone; Martino Introna; Ranieri Cancedda; Maddalena Mastrogiacomo
Journal:  Stem Cells Dev       Date:  2015-03-18       Impact factor: 3.272

6.  Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells.

Authors:  Arianna Barbara Lovati; Bruna Corradetti; Anna Lange Consiglio; Camilla Recordati; Elisa Bonacina; Davide Bizzaro; Fausto Cremonesi
Journal:  Vet Res Commun       Date:  2010-12-31       Impact factor: 2.459

7.  The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system.

Authors:  Qin Wang; Xiaofeng Li; Jing Luo; Li Zhang; Lihui Ma; Zhiqin Lv; Lijin Xue
Journal:  BMC Musculoskelet Disord       Date:  2012-12-13       Impact factor: 2.362

8.  Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma.

Authors:  Bo Qiao; Wei Shui; Li Cai; Shuquan Guo; Dianming Jiang
Journal:  Drug Des Devel Ther       Date:  2015-02-17       Impact factor: 4.162

9.  Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications.

Authors:  Andrea Lindenmair; Tim Hatlapatka; Gregor Kollwig; Simone Hennerbichler; Christian Gabriel; Susanne Wolbank; Heinz Redl; Cornelia Kasper
Journal:  Cells       Date:  2012-11-12       Impact factor: 6.600

Review 10.  Umbilical Cord Tissue-Derived Cells as Therapeutic Agents.

Authors:  Olga Maslova; Miroslav Novak; Peter Kruzliak
Journal:  Stem Cells Int       Date:  2015-07-12       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.